Style | Citing Format |
---|---|
MLA | Nabizadeh F, et al.. "Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review." Pharmacological Research, vol. 177, no. , 2022, pp. -. |
APA | Nabizadeh F, Momtaz S, Ghanbarimovahed M, Qalekhani F, Mohsenpour H, Aneva IY, Bishayee A, Farzaei MH, Bishayee A (2022). Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review. Pharmacological Research, 177(), -. |
Chicago | Nabizadeh F, Momtaz S, Ghanbarimovahed M, Qalekhani F, Mohsenpour H, Aneva IY, Bishayee A, Farzaei MH, Bishayee A. "Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review." Pharmacological Research 177, no. (2022): -. |
Harvard | Nabizadeh F et al. (2022) 'Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review', Pharmacological Research, 177(), pp. -. |
Vancouver | Nabizadeh F, Momtaz S, Ghanbarimovahed M, Qalekhani F, Mohsenpour H, Aneva IY, et al.. Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review. Pharmacological Research. 2022;177():-. |
BibTex | @article{ author = {Nabizadeh F and Momtaz S and Ghanbarimovahed M and Qalekhani F and Mohsenpour H and Aneva IY and Bishayee A and Farzaei MH and Bishayee A}, title = {Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review}, journal = {Pharmacological Research}, volume = {177}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Nabizadeh F AU - Momtaz S AU - Ghanbarimovahed M AU - Qalekhani F AU - Mohsenpour H AU - Aneva IY AU - Bishayee A AU - Farzaei MH AU - Bishayee A TI - Pediatric Acute Lymphoblastic Leukemia Management Using Multitargeting Bioactive Natural Compounds: A Systematic and Critical Review JO - Pharmacological Research VL - 177 IS - SP - EP - PY - 2022 ER - |